Literature DB >> 20513143

Nasal epithelial cells are a reliable source to study splicing variants in Usher syndrome.

Christel Vaché1, Thomas Besnard, Catherine Blanchet, David Baux, Lise Larrieu, Valérie Faugère, Michel Mondain, Christian Hamel, Sue Malcolm, Mireille Claustres, Anne-Françoise Roux.   

Abstract

We have shown that nasal ciliated epithelium, which can be easily biopsied under local anesthetic, provides a good source of RNA transcripts from eight of the nine known genes that cause Usher syndrome, namely, MYO7A, USH1C, CDH23, PCDH15, USH1G for Usher type 1, and USH2A, GPR98, WHRN for Usher type 2. Furthermore, the known or predicted effect on mRNA splicing of eight variants was faithfully reproduced in the biopsied sample as measured by nested RT-PCR. These included changes at the canonical acceptor site, changes within the noncanonical acceptor site and both synonymous and nonsynonymous amino acid changes. This shows that mRNA analysis by this method will help in assessing the pathogenic effect of variants, which is a major problem in the molecular diagnosis of Usher syndrome.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20513143     DOI: 10.1002/humu.21255

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  9 in total

1.  The Usher gene cadherin 23 is expressed in the zebrafish brain and a subset of retinal amacrine cells.

Authors:  Greta Glover; Kaspar P Mueller; Christian Söllner; Stephan C F Neuhauss; Teresa Nicolson
Journal:  Mol Vis       Date:  2012-09-05       Impact factor: 2.367

2.  MYO7A and USH2A gene sequence variants in Italian patients with Usher syndrome.

Authors:  Andrea Sodi; Alessandro Mariottini; Ilaria Passerini; Vittoria Murro; Iryna Tachyla; Benedetta Bianchi; Ugo Menchini; Francesca Torricelli
Journal:  Mol Vis       Date:  2014-12-23       Impact factor: 2.367

3.  A 4.6 Mb Inversion Leading to PCDH15-LINC00844 and BICC1-PCDH15 Fusion Transcripts as a New Pathogenic Mechanism Implicated in Usher Syndrome Type 1.

Authors:  Christel Vaché; Jacques Puechberty; Valérie Faugère; Floriane Darmaisin; Alessandro Liquori; David Baux; Catherine Blanchet; Gema Garcia-Garcia; Isabelle Meunier; Franck Pellestor; Michel Koenig; Anne-Françoise Roux
Journal:  Front Genet       Date:  2020-07-02       Impact factor: 4.599

4.  Spectrum of MYO7A Mutations in an Indigenous South African Population Further Elucidates the Nonsyndromic Autosomal Recessive Phenotype of DFNB2 to Include Both Homozygous and Compound Heterozygous Mutations.

Authors:  Rosemary Ida Kabahuma; Wolf-Dieter Schubert; Christiaan Labuschagne; Denise Yan; Susan Halloran Blanton; Michael Sean Pepper; Xue Zhong Liu
Journal:  Genes (Basel)       Date:  2021-02-15       Impact factor: 4.096

5.  Molecular Inversion Probe-Based Sequencing of USH2A Exons and Splice Sites as a Cost-Effective Screening Tool in USH2 and arRP Cases.

Authors:  Janine Reurink; Adrian Dockery; Dominika Oziębło; G Jane Farrar; Monika Ołdak; Jacoline B Ten Brink; Arthur A Bergen; Tuula Rinne; Helger G Yntema; Ronald J E Pennings; L Ingeborgh van den Born; Marco Aben; Jaap Oostrik; Hanka Venselaar; Astrid S Plomp; M Imran Khan; Erwin van Wijk; Frans P M Cremers; Susanne Roosing; Hannie Kremer
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

6.  Study of USH1 splicing variants through minigenes and transcript analysis from nasal epithelial cells.

Authors:  María José Aparisi; Gema García-García; Elena Aller; María Dolores Sequedo; Cristina Martínez-Fernández de la Cámara; Regina Rodrigo; Miguel Armengot; Julio Cortijo; Javier Milara; Manuel Díaz-LLopis; Teresa Jaijo; José María Millán
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

7.  Screening for duplications, deletions and a common intronic mutation detects 35% of second mutations in patients with USH2A monoallelic mutations on Sanger sequencing.

Authors:  Heather B Steele-Stallard; Polona Le Quesne Stabej; Eva Lenassi; Linda M Luxon; Mireille Claustres; Anne-Francoise Roux; Andrew R Webster; Maria Bitner-Glindzicz
Journal:  Orphanet J Rare Dis       Date:  2013-08-08       Impact factor: 4.123

8.  Experience of targeted Usher exome sequencing as a clinical test.

Authors:  Thomas Besnard; Gema García-García; David Baux; Christel Vaché; Valérie Faugère; Lise Larrieu; Susana Léonard; Jose M Millan; Sue Malcolm; Mireille Claustres; Anne-Françoise Roux
Journal:  Mol Genet Genomic Med       Date:  2013-07-10       Impact factor: 2.183

9.  Aberrant Splicing Events Associated to CDH23 Noncanonical Splice Site Mutations in a Proband with Atypical Usher Syndrome 1.

Authors:  Rebeca Valero; Marta de Castro-Miró; Sofía Jiménez-Ochoa; Juan José Rodríguez-Ezcurra; Gemma Marfany; Roser Gonzàlez-Duarte
Journal:  Genes (Basel)       Date:  2019-09-21       Impact factor: 4.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.